Thanks for the link -Looks like there is going to be another presentation.
--Dick
RESPONSE BIOMEDICAL CORP.
8855 Northbrook Court
Burnaby, British Columbia
Canada V5J 5J1
Canadian Venture Exchange: RBM
INVESTOR ADVISORY
RESPONSE BIOMEDICAL TO PRESENT AND EXHIBIT
AT VANCOUVER INVESTMENT CONFERENCE
Vancouver, British Columbia, January 17, 2002. Response Biomedical Corp.
(RBM: CDNX) developer of the RAMP(TM) diagnostic system, advises it will be
an exhibitor at the Vancouver Investment Conference on January 20 and 21,
2002.
The Company will participate in the Biotech Focus Panel between 11 - 11:15
am on January 20th, and follow with an investor presentation at 12:00 -
12:30 pm in the Tweedsmuir Room. Response Biomedical will be at booth
number 94 in the Exhibit Hall.
The conference is FREE for attendees that pre-register. Complete conference
details and pre-registration information is available at
cambridgeconferences.com.
Following is information on the conference from organizers Cambridge House
International. We look forward to seeing you.
VANCOUVER INVESTMENT CONFERENCE
Sunday and Monday, Jan. 20 & 21, 2002
Fairmont Hotel Vancouver, 900 W. Georgia Street
THIS IS CANADA'S LARGEST AND BEST INVESTMENT CONFERENCE!
Over 50 speakers with advice on Speculative Investing, Resource Exploration
(diamonds, gold, PGMs, metals), Oil & Gas, Biotechnology, Investment
Strategies - and MORE! PLUS - Over 70 companies in the Exhibit Hall.
Two full days and it is all FREE. Sunday, Monday 9 - 5 both days.
Come for the entire conference or drop in to listen to your preferred
speakers - and bring a friend. We ask you to pre-register on the web as it
greatly helps with the logistics - your name/entry badge will be waiting for
you at the registration desk.
Some Keynote Speakers:
Sunday: 11:00 a.m.
Dr. Pat McGeer: BCs legendary visionary thinker and a world leader in brain
research speaks on the future of biotech.
Sunday: 1:00 p.m.
Michael Levy, media business personality, offers an update on the world
situation and its effect on BC.
Sunday: 3:15 p.m. Bob Bishop of Gold Mining Stock Report - reports. He is
followed by Ian Gordon of the Long Wave Analyst.
Monday: 11:30 a.m.
David Tice, of the Prudent Bear Fund and an analyst ranked in the top 1% in
the US by Business Week magazine, talks about his fund's strategic
investment strategy and why he is bullish on Canadian junior gold
exploration companies.
Monday: 1:00 p.m.
John Kaiser of Kaiser's Bottom Fishing Report outlines the exciting
developments which could give Canada a 50% market share of the world's gem
quality diamonds. (Speakers following include David Morgan of Silver
Investor and David Skarica, Canada's widely quoted technical analyst.)
Monday: 4:30 p.m.
Michael Levy hosts a closing panel on world perspectives with a great
line-up of speakers.
The entire speaker list and agenda can be viewed at
cambridgeconferences.com.
It includes Bob Bishop, David Coffin, Eric Coffin, Lawrence Roulston, Robert
Chapman, Ian Gordon, Dr. Art Ettlinger, Graeme Currie, David Skarica, Ken
Korb, Jay Taylor, Louis Paquette, Brent Cook, David Morgan, David Pescod,
Fred Kozak, Ryan Irvine, Brent Larsen - PLUS a long list of corporate
presenters.
ALSO, CHECK OUT THESE FREE COURSES OFFERED BY CAMBRIDGE HOUSE INVESTOR
COLLEGE
Street Smart Investing with Louis Paquette
Analyzing Diamond juniors with John Kaiser
Re-structuring your Personal Portfolio for Today's Reality with Jeanne
Campbell
About Response Biomedical Corp.
Response Biomedical develops quantitative, point-of-care diagnostic tests
for use with its RAMP Reader to be used in hospitals, clinics, laboratories
and physicians' offices worldwide. The Company's patented Rapid Analyte
Measurement Platform (RAMP*) technology is a unique, portable, easy-to-use
immunoassay system which combines the positive attributes of lateral flow
immunoassays - simplicity, specificity, reliability and low cost - with the
ability to provide a quantitative result at a level of sensitivity and
accuracy currently attainable only with laboratory based analyzers. RAMP
has the potential to be used with more than 250 medical and non-medical
tests that are currently performed in laboratories including detection of
biological materials used in bioterrorism. Response Biomedical's shares are
listed on the Canadian Venture Exchange under the trading symbol "RBM". For
further information, visit the Company's website at www.responsebio.com.
The Canadian Venture Exchange has not reviewed and does not accept
responsibility for the adequacy of the content of the information contained
herein. The statements made in this investor advisory and the presentation
to which this advisory refers to, may contain certain forward-looking
statements that involve a number of risks and uncertainties. Actual events
or results may differ from the Company's expectations.
Company Contact:
John Gomez
Manager, Corporate Communications
Response Biomedical Corp.
Tel (604) 681-4101
Fax (604) 412-9830
Email: jgomez@responsebio.com |
